科室与专家门诊
妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都有院区。医务人员掌握数几十种专业技能，齐心协力，确保高品质治疗与成功康复。
研究
Mayo Clinic researchers are involved in many studies related to triple-negative breast cancer (TNBC). Mayo Clinic doctors often inform eligible patients about opportunities to participate in research studies and clinical trials related to advancements in the treatment of breast cancer.
Areas of research include:
- Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.
- Studying whether people with early-stage triple-negative breast cancer (TNBC) who have high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates.
- Using viruses to treat noninvasive breast cancer, triple-negative breast cancer and metastatic breast cancer.
- Studying breast imaging techniques, such as dynamic contrast-enhanced MRI, contrast-enhanced digital mammography and molecular breast imaging.
- Making treatment safer using new technology, such as proton beam therapy to shape radiation beams that reach left-sided breast cancer but spare the heart.
Mayo Clinic Comprehensive Cancer Center is one of a select group of facilities that received a Specialized Program of Research Excellence (SPORE) grant for breast cancer research from the U.S. National Cancer Institute. Learn more about the Mayo Clinic Breast Cancer SPORE.
Publications
See a list of publications about triple-negative breast cancer by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.